-
04:08:13 AM
Sign in with email
Forgot your password?
Register with email
Account Verification

GSK Stock News

06/29/22 8:00 AM
NYSE : GSK
GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community
GSK plc today announced the first recipient of the Target the Future Think Tank Challenge £70,000 grant to the HealthTree Foundation, a non-profit organization helping patients learn more about their health and become their own best advocates. GSK’ s grant will help support the HealthTree Foundation as it develops digital delivery tools to distribute...
RHEA-AI
very positive
06/06/22 10:00 AM
NYSE : GSK
fda approval
GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older
GSK plc today announced that the US Food and Drug Administration has approved PRIORIX for active immunisation for the prevention of measles, mumps and rubella in individuals 12 months of age and older. PRIORIX is currently licenced in more than 100 countries worldwide, including all European countries, Canada, Australia and New Zealand, with more than 800...
RHEA-AI
negative
04/13/22 2:05 AM
Nasdaq, NYSE : SRRA, GSK
acquisitionlow float
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
GlaxoSmithKline plc and Sierra Oncology, Inc today announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California- based, late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer, for $55 per share of common stock in cash representing an approximate...
RHEA-AI
positive
04/06/22 10:00 AM
NYSE : GSK
covid-19
New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+
According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles– a painful rash– compared to those who haven’ t been diagnosed with COVID-19. This research was published in the Infectious Diseases Society of America’ s Open Forum Infectious Diseases.. “This is the first epidemiological...
RHEA-AI
negative
03/29/22 1:30 PM
NYSE : PFE, GSK
fda approval
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi B.V. as shareholders, today announced that the US Food and Drug Administration has approved Cabenuva for the treatment of HIV-1 in virologically suppressed adolescents who are 12 years of age or older and weigh at least 35 kg on a stable...
RHEA-AI
neutral